Literature DB >> 17557355

Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.

Tatiana Witjas1, Elsa Kaphan, Jean Régis, Elisabeth Jouve, André Ali Chérif, Jean-Claude Péragut, Jean Philippe Azulay.   

Abstract

The aim of this study was to assess the outcome of nonmotor fluctuations (NMF) after chronic Subthalamic nucleus (STN) Deep Brain Stimulation (DBS) in Parkinson's disease(PD). Chronic stimulation of the STN has proved to be an effective treatment for advanced PD with motor complications. The outcome of NMF, which are also disabling, remains unknown. Forty-patients underwent bilateral STN stimulation. Each patient was interviewed before and after 1 yr of STN DBS with a structured questionnaire about their NMF. After 1 yr of chronic stimulation, the improvement in the motor score (UPDRS III) and dyskinesia amounted respectively to 67.4 and 76.3%. The decrease in motor fluctuations (MF) was 59% and 13 patients reported that their MF had disappeared. Comparatively, a reduction of the total number of NMF was also observed (mean number preoperatively: 15.6 per patient, postoperatively: 6.6). Most of the nonmotor fluctuating symptoms occurred in the "off" state preoperatively and no longer depended on the patient's motor state after surgery. The improvement in NMF was not identical for the different categories: pain/sensory fluctuations showed the best response to STN DBS (84.2%). Dysautonomic and cognitive fluctuations were also markedly improved (>60%) while psychic fluctuations remained the most frequent postoperative NMF observed. Some incapacitating manifestations such as drenching sweats and akathisia showed a remarkably good response to STN stimulation. In conclusion STN DBS alleviates NMF. It has strikingly successful effects on sensory, dysautonomic and cognitive fluctuations. However, psychic fluctuations respond less consistently to this treatment. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17557355     DOI: 10.1002/mds.21602

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 3.  Deep brain stimulation for Parkinson's disease.

Authors:  Patricia Limousin; Irene Martinez-Torres
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 4.  Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease.

Authors:  Jean-Philippe Azulay; Tatiana Witjas; Alexandre Eusebio
Journal:  J Neural Transm (Vienna)       Date:  2012-12-23       Impact factor: 3.575

Review 5.  [Long-term care after deep brain stimulation of patients with Parkinson's disease].

Authors:  F Sixel-Döring; G Ebersbach
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

Review 6.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 7.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  DBS amplitude setting can improve aspects of quality of life in patients with Parkinson's disease.

Authors:  Marek Baláž; Martina Bočková; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2013-03-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.